Nestmedic S.A. (WSE:NST)

Nestmedic Income Statement

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1.15	1.02	0.97	1.55	1.87	0.65
Revenue Growth (YoY)	51.63%	5.06%	-37.39%	-17.08%	185.23%	76.44%
Cost of Revenue	0.22	0.2	0.31	0.6	1.06	0.56
Gross Profit	0.93	0.81	0.65	0.95	0.81	0.1
Selling, General & Admin	4.15	3.98	4.65	6.43	6.63	3.65
Other Operating Expenses	-0.09	-0.05	0.01	0.29	0.51	0.08
Operating Expenses	5	4.89	5.7	7.27	7.52	3.92
Operating Income	-4.07	-4.08	-5.05	-6.32	-6.71	-3.82
Interest Expense	-0.18	-0.21	-0.22	-0.41	-0.31	-0.37
Interest & Investment Income	-	-	0.03	0.03	0	0.05
Other Non Operating Income (Expenses)	-0.18	-0.16	-0.07	-0.09	0.01	-0.04
EBT Excluding Unusual Items	-4.42	-4.45	-5.3	-6.8	-7.01	-4.18
Gain (Loss) on Sale of Investments	0	-	-	-0	-	-
Asset Writedown	0.07	0.07	-0.08	0.03	2.06	0.28
Pretax Income	-4.35	-4.37	-5.38	-6.77	-4.95	-3.91
Net Income	-4.35	-4.37	-5.38	-6.77	-4.95	-3.91
Net Income to Common	-4.35	-4.37	-5.38	-6.77	-4.95	-3.91
Shares Outstanding (Basic)	-	-	27	25	19	10
Shares Outstanding (Diluted)	-	-	27	25	19	10
Shares Change (YoY)	-	-	10.64%	31.02%	86.94%	39.63%
EPS (Basic)	-	-	-0.20	-0.27	-0.26	-0.39
EPS (Diluted)	-	-	-0.20	-0.27	-0.26	-0.39
Free Cash Flow	-8.19	-7.31	-4.31	-6.68	-8.37	-8.07
Free Cash Flow Per Share	-	-	-0.16	-0.27	-0.45	-0.80
Gross Margin	80.66%	79.88%	67.56%	61.51%	43.36%	14.61%
Operating Margin	-352.61%	-400.31%	-520.86%	-408.12%	-359.46%	-583.99%
Profit Margin	-377.06%	-429.55%	-555.11%	-437.32%	-265.30%	-596.66%
Free Cash Flow Margin	-710.20%	-717.71%	-444.67%	-431.65%	-448.14%	-1233.14%
EBITDA	-3.12	-3.13	-4.83	-5.76	-6.33	-3.6
D&A For EBITDA	0.94	0.95	0.22	0.55	0.38	0.22
EBIT	-4.07	-4.08	-5.05	-6.32	-6.71	-3.82
Revenue as Reported	1.15	1.02	0.97	1.55	1.87	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.